DK47089A - Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer - Google Patents

Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer

Info

Publication number: DK47089A
Authority: DK; Denmark
Prior art keywords: cancer; timal; tumors; procedures; agents
Prior art date: 1988-02-03

Application number

DK047089A

Other languages

English (en)

Other versions

DK47089D0 (da

Inventor

Karl Groke

Hans Miggitsch

Horst Musil

Josef Polzer

Original Assignee

Leopold & Co Chem Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-03

Filing date

1989-02-02

Publication date

1989-09-15

1989-02-02 Application filed by Leopold & Co Chem Pharm filed Critical Leopold & Co Chem Pharm

1989-02-02 Publication of DK47089D0 publication Critical patent/DK47089D0/da

1989-09-15 Publication of DK47089A publication Critical patent/DK47089A/da

Links

206010028980 Neoplasm Diseases 0.000 title 2
201000011510 cancer Diseases 0.000 title 1
230000000254 damaging effect Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000126 substance Substances 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 2
XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 abstract 2
NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 abstract 2
SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 abstract 1
SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 abstract 1
HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 1
229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
235000020960 dehydroascorbic acid Nutrition 0.000 abstract 1
239000011615 dehydroascorbic acid Substances 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
229940059082 douche Drugs 0.000 abstract 1
239000003978 infusion fluid Substances 0.000 abstract 1
229940043353 maltol Drugs 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
238000011275 oncology therapy Methods 0.000 abstract 1
MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 abstract 1
FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 1
235000012141 vanillin Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK047089A 1988-02-03 1989-02-02 Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer DK47089A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT218/88A AT393221B (de)	1988-02-03	1988-02-03	Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken

Publications (2)

Publication Number	Publication Date
DK47089D0 DK47089D0 (da)	1989-02-02
DK47089A true DK47089A (da)	1989-09-15

Family

ID=3484658

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK047089A DK47089A (da)	1988-02-03	1989-02-02	Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer

Country Status (7)

Country	Link
US (1)	US5006551A (da)
EP (1)	EP0326826B1 (da)
JP (1)	JPH01226810A (da)
AT (2)	AT393221B (da)
DE (1)	DE58901002D1 (da)
DK (1)	DK47089A (da)
ES (1)	ES2033021T3 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03165602A (ja) *	1989-11-24	1991-07-17	Murata Mfg Co Ltd	誘電体共振器
HU207800B (en) *	1990-05-10	1993-06-28	Andras Sikter	Process for producing composition for improving condition and for treating different illnesses
NZ258019A (en) *	1992-11-06	1998-12-23	Greystone Medical Group Inc	Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
US5629327A (en) *	1993-03-01	1997-05-13	Childrens Hospital Medical Center Corp.	Methods and compositions for inhibition of angiogenesis
GB9306741D0 (en) *	1993-03-31	1993-05-26	Biocure Ltd	Compounds
US6209259B1 (en) *	1997-07-11	2001-04-03	Encap, Llc	Seeding treatments
JP2002531511A (ja) *	1998-12-07	2002-09-24	エコスマートテクノロジーズ，インコーポレーテッド	シグナル伝達調節物質と天然植物精油を用いた癌治療薬配合物および方法
EP1282416A2 (en) *	2000-05-19	2003-02-12	Progenics Pharmaceuticals, Inc.	Dehydroascorbic acid formulations and uses thereof
AT411730B (de) *	2002-05-17	2004-05-25	Groke Karl Dr	Mittel zur raucher-entwöhnung oder zur alkohol-entwöhnung
SE0201880D0 (sv) *	2002-06-19	2002-06-19	Milenca Gardovic	Komposition för att behandla hudåkommor och för att förbättra hårtillväxt
AT412447B (de) *	2002-11-27	2005-03-25	C Y L Handelsges M B H	Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung
US20050124684A1 (en) *	2003-08-29	2005-06-09	Ying Du	5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production
EP1824470B1 (en) *	2004-12-17	2014-08-06	Alan B. Cash	Method for extending lifespan and delaying the onset of age-related disease
PL372183A1 (pl) *	2005-01-11	2006-07-24	Sgp & Sons Ab	Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
US20110105617A1 (en) *	2005-01-11	2011-05-05	Sgp & Sons Ab	Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
AT503385B1 (de) *	2006-03-20	2008-05-15	C Y L Pharmazeutika Gmbh	Mittel zur behandlung von oxidativem stress
DE102007007629A1 (de)	2007-02-16	2008-08-21	Evonik Degussa Gmbh	Verfahren zur Herstellung von 5-Hydroxymethyl-furfural über 5-Acyloxymethyl-furfural als Zwischenprodukt
EP2255623A1 (en) *	2009-05-26	2010-12-01	Volker Wagner-Solbach	Plant nutriments
WO2014070769A1 (en)	2012-10-29	2014-05-08	The University Of North Carolina At Chapel Hill	Methods and compositions for treating mucosal tissue disorders
DE102013106530A1 (de) *	2013-06-21	2014-12-24	Christoph Pallua	Krebsmedikament
WO2018057737A1 (en)	2016-09-22	2018-03-29	Cash Alan B	Method to alleviate the symptoms of pms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1125675A (en) *	1966-02-10	1968-08-28	Kyowa Hakko Kogyo Kk	Stable ascorbic acid composition and process for preparing the same
JPS52108027A (en) *	1976-03-09	1977-09-10	Rikagaku Kenkyusho	Anticarcinogen
JPS5412312A (en) *	1977-06-30	1979-01-30	Otsuka Chem Co Ltd	Preparation of ketazine
JPS5470428A (en) *	1977-11-11	1979-06-06	Rikagaku Kenkyusho	Carcinostatic agent
JPS54126731A (en) *	1978-03-20	1979-10-02	Rikagaku Kenkyusho	Carcinostatic agent
JPS579712A (en) *	1980-06-20	1982-01-19	Fukumi Morishige	Instilling (dripping) liquid for intravenous injection
ATE11736T1 (de) *	1980-12-23	1985-02-15	Dr. Franz Koehler Chemie Gmbh	Protektive loesung fuer herz und niere und verfahren zu deren herstellung.
WO1983002464A1 (en) *	1982-01-04	1983-07-21	Seymour, Robert, Stephen	Diameter control in czochralski crystal growth
EP0221728B1 (en) *	1985-10-22	1992-07-15	Anthony N. Silvetti, Sr.	Monosaccharide containing wound healing preparation

1988
- 1988-02-03 AT AT218/88A patent/AT393221B/de not_active IP Right Cessation
1989
- 1989-01-12 ES ES89100493T patent/ES2033021T3/es not_active Expired - Lifetime
- 1989-01-12 AT AT89100493T patent/ATE74006T1/de not_active IP Right Cessation
- 1989-01-12 EP EP89100493A patent/EP0326826B1/de not_active Expired - Lifetime
- 1989-01-12 DE DE8989100493T patent/DE58901002D1/de not_active Expired - Fee Related
- 1989-01-24 US US07/301,035 patent/US5006551A/en not_active Expired - Lifetime
- 1989-02-02 DK DK047089A patent/DK47089A/da not_active Application Discontinuation
- 1989-02-02 JP JP1022747A patent/JPH01226810A/ja active Pending

Also Published As

Publication number	Publication date
EP0326826B1 (de)	1992-03-25
ATE74006T1 (de)	1992-04-15
DE58901002D1 (de)	1992-04-30
US5006551A (en)	1991-04-09
ATA21888A (de)	1991-02-15
EP0326826A1 (de)	1989-08-09
DK47089D0 (da)	1989-02-02
AT393221B (de)	1991-09-10
ES2033021T3 (es)	1996-07-16
JPH01226810A (ja)	1989-09-11

Legal Events

Date	Code	Title	Description
1990-09-17	AHB	Application shelved due to non-payment
2000-10-09	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK47089D0 (da)	1989-02-02	Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
EA200000759A1 (ru)	2001-04-23	Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE209908T1 (de)	2001-12-15	RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DE69132688D1 (de)	2001-09-20	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
SE8402550D0 (sv)	1984-05-11	N-substituerade deriavat av moranolin
JPS5756427A (en)	1982-04-05	Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one
SE8903914D0 (sv)	1989-11-22	Oral composition for the treatment of inflammatory bowel diseases
SE8000435L (sv)	1980-07-20	N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
EA200100127A1 (ru)	2001-10-22	Производные фенилксантина
ATE197670T1 (de)	2000-12-15	Parenterales busulfan zur behandlung von malignen krankheiten
ATE16191T1 (de)	1985-11-15	Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
SE7902742L (sv)	1979-09-29	Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
KR910005858A (ko)	1991-04-27	지방산 요법
ATE38151T1 (de)	1988-11-15	Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO162283C (no)	1989-12-06	Analogifremgangsmaate til fremstilling av nye terapeutisk,aktive substituerte 3-fenoksy-1-alkoksykarbonyl-alkylamino-propanoler-2.
NO172537C (no)	1993-08-04	Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
NO153495C (no)	1986-05-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater.
DK418986A (da)	1987-03-06	Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
KR890000108A (ko)	1989-03-11	종양 치료용 약제학적 조성물
ATE5073T1 (de)	1983-11-15	5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK225689D0 (da)	1989-05-08	Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
DE59108104D1 (de)	1996-09-26	Arzneimittel enthaltend cd14
DE3650368D1 (de)	1995-09-21	Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
RU97101420A (ru)	1998-09-10	Способ лечения тонзиллита